Pennsylvania-based Geneos Therapeutics is using its clinically validated GT-EPIC platform to generate cancer immunotherapies with high neoantigen payloads, and more. Despite the promise of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback